ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991

ACS-Roosevelt Awards Announced

June 22, 1979

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010